-- Prototype of the Innovative Combined Technology on Demonstration at AACN Expo --
LAKE FOREST, Ill., May 19 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced the coming integration of its clinician-friendly Symbiq(R) smart infusion pump and industry-leading EndoTool(R) glucose management software. A prototype of this technologically advanced combination system is being demonstrated at the American Association of Critical Care Nurses (AACN) National Teaching Institute & Critical Care Exposition in New Orleans through May 21.
"Unveiling the integrated Symbiq and EndoTool development effort illustrates Hospira's commitment to providing cutting-edge medication delivery technology, and ensuring compatibility between and integration of important hospital technologies," said Philip Settimi, M.D., vice president, Global Marketing, Global Devices, Hospira.
As a leading provider of advanced medication delivery systems, Hospira offers hospitals and health institutions innovative solutions to improve clinician efficiency and patient safety. The Symbiq infusion system, which helps prevent medication errors, and the EndoTool glucose management system, a clinical-decision support tool designed to aid workflow, are novel technologies created with clinician input throughout the development process to ensure maximum usability. The AACN Expo attendees will be able to provide feedback regarding the integrated Symbiq/EndoTool system.
The Symbiq infusion system is a highly advanced, easy-to-use device with several clinician-friendly features to help improve workflow and decrease medication errors. An estimated 1.5 million medication errors occur annually, with 400,000 preventable drug-related injuries occurring in
|SOURCE Hospira, Inc.|
Copyright©2009 PR Newswire.
All rights reserved